Schedule 13G ownership disclosure

INFINITY PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 45665G303

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,773,400
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-16-001076
Form type
SC 13G/A
Filer
GOLDMAN SACHS ASSET MANAGEMENT, L.P.
CIK
CIK 1229262
Filed
Jan 11, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub